Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 10, 2003. The report is a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to corporate governance disclosures regarding share ownership.
Material Changes
On March 7, 2003, the Administrators of the SmithKline Beecham Employee Benefit Trust notified the company that 13,446 Ordinary shares were transferred from the Trust to a participant of the SmithKline Beecham 1991 Share Option Plan.
Management Commentary and Risks
The filing notes that the Trust is a discretionary fund for current and former employees. Directors Dr. J P Garnier and John Coombe hold an interest in the shares held within the fund in the same capacity as other employees. No specific risks, contingencies, or unusual financial items are detailed in this text.
Investor Verification Points
- Confirm the total number of shares held by the SmithKline Beecham Employee Benefit Trust following the transfer.
- Verify the specific identity of the Share Option Plan participant who received the 13,446 shares.
- Review the full 20-F annual report for comprehensive financial performance data not included in this 6-K.